Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 300% % -28%
Quick Ratio 9.8% % -36%
Debt-to-equity 162% % 24%
Return On Equity -41% % 45%
Return On Assets -16% % 51%
Operating Margin -31% % 73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152,665,188 shares 3.4%
Common Stock, Shares, Outstanding 152,581,042 shares 3.4%
Entity Public Float $416,000,000 USD -45%
Common Stock, Value, Issued $15,000 USD 7.1%
Weighted Average Number of Shares Outstanding, Basic 152,432,307 shares 3.3%
Weighted Average Number of Shares Outstanding, Diluted 163,162,107 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $252,754,000 USD 43%
Research and Development Expense $95,198,000 USD -12%
Selling and Marketing Expense $91,665,000 USD 7.7%
General and Administrative Expense $71,200,000 USD -5.7%
Costs and Expenses $330,941,000 USD -12%
Operating Income (Loss) $78,187,000 USD 61%
Net Income (Loss) Attributable to Parent $79,612,000 USD 59%
Earnings Per Share, Basic 0 USD/shares 60%
Earnings Per Share, Diluted 0 USD/shares 60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $55,034,000 USD 45%
Accounts Receivable, after Allowance for Credit Loss, Current $44,821,000 USD 9.8%
Inventory, Net $9,933,000 USD -17%
Assets, Current $281,435,000 USD -8.7%
Property, Plant and Equipment, Net $37,498,000 USD -27%
Operating Lease, Right-of-Use Asset $41,988,000 USD -9.8%
Goodwill $118,972,000 USD 0%
Other Assets, Noncurrent $1,836,000 USD -31%
Assets $490,610,000 USD -12%
Accounts Payable, Current $10,267,000 USD 40%
Employee-related Liabilities, Current $12,681,000 USD 2.8%
Accrued Liabilities, Current $7,205,000 USD 19%
Contract with Customer, Liability, Current $41,337,000 USD -20%
Liabilities, Current $83,361,000 USD -4.9%
Contract with Customer, Liability, Noncurrent $1,206,000 USD -96%
Operating Lease, Liability, Noncurrent $72,361,000 USD -12%
Other Liabilities, Noncurrent $20,000 USD 0%
Liabilities $286,357,000 USD -15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $211,000 USD -58%
Retained Earnings (Accumulated Deficit) $1,349,744,000 USD -6.3%
Stockholders' Equity Attributable to Parent $204,435,000 USD -8.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $204,253,000 USD -8.6%
Liabilities and Equity $490,610,000 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $28,484,000 USD 26%
Net Cash Provided by (Used in) Financing Activities $5,451,000 USD 12289%
Net Cash Provided by (Used in) Investing Activities $25,573,000 USD -43%
Common Stock, Shares Authorized 340,000,000 shares 0%
Common Stock, Shares, Issued 152,581,042 shares 3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,540,000 USD -59%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,373,000 USD 3.7%
Deferred Tax Assets, Valuation Allowance $435,509,000 USD 8.2%
Deferred Tax Assets, Gross $447,090,000 USD 7.2%
Operating Lease, Liability $81,803,000 USD -11%
Depreciation $4,312,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $1,259,000 USD -17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $79,898,000 USD 59%
Lessee, Operating Lease, Liability, to be Paid $97,093,000 USD -13%
Property, Plant and Equipment, Gross $136,433,000 USD -3.6%
Operating Lease, Liability, Current $9,442,000 USD -5.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,944,000 USD -3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,330,000 USD -13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15,290,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $12,282,000 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $274,535,000 USD 9.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $10,710,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $12,630,000 USD 2.8%
Operating Lease, Payments $3,000,000 USD -19%
Additional Paid in Capital $1,553,953,000 USD 4.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,698,000 USD -0.35%
Deferred Tax Assets, Net of Valuation Allowance $11,581,000 USD -20%
Share-based Payment Arrangement, Expense $51,595,000 USD -8.4%
Interest Expense $11,776,000 USD 1.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%